1. Home
  2. HOWL vs INTT Comparison

HOWL vs INTT Comparison

Compare HOWL & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • INTT
  • Stock Information
  • Founded
  • HOWL 2017
  • INTT 1981
  • Country
  • HOWL United States
  • INTT United States
  • Employees
  • HOWL N/A
  • INTT N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • HOWL Health Care
  • INTT Technology
  • Exchange
  • HOWL Nasdaq
  • INTT Nasdaq
  • Market Cap
  • HOWL 87.4M
  • INTT 91.4M
  • IPO Year
  • HOWL 2021
  • INTT 1997
  • Fundamental
  • Price
  • HOWL $1.36
  • INTT $8.66
  • Analyst Decision
  • HOWL Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • HOWL 2
  • INTT 2
  • Target Price
  • HOWL $9.50
  • INTT $16.00
  • AVG Volume (30 Days)
  • HOWL 263.3K
  • INTT 28.9K
  • Earning Date
  • HOWL 03-06-2025
  • INTT 03-26-2025
  • Dividend Yield
  • HOWL N/A
  • INTT N/A
  • EPS Growth
  • HOWL N/A
  • INTT N/A
  • EPS
  • HOWL N/A
  • INTT 0.22
  • Revenue
  • HOWL $3,386,000.00
  • INTT $121,971,000.00
  • Revenue This Year
  • HOWL N/A
  • INTT $7.31
  • Revenue Next Year
  • HOWL $34.17
  • INTT $5.77
  • P/E Ratio
  • HOWL N/A
  • INTT $37.76
  • Revenue Growth
  • HOWL N/A
  • INTT N/A
  • 52 Week Low
  • HOWL $1.26
  • INTT $6.28
  • 52 Week High
  • HOWL $8.19
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • INTT 51.29
  • Support Level
  • HOWL $1.26
  • INTT $8.70
  • Resistance Level
  • HOWL $1.45
  • INTT $9.30
  • Average True Range (ATR)
  • HOWL 0.09
  • INTT 0.41
  • MACD
  • HOWL 0.02
  • INTT -0.03
  • Stochastic Oscillator
  • HOWL 45.45
  • INTT 42.20

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: